CVT-313 is primarily used in biochemical research as a potent and selective inhibitor of cyclin-dependent kinase 2 (CDK2). It is particularly valuable in studying cell cycle regulation and the mechanisms of cell proliferation. Researchers utilize CVT-313 to investigate the role of CDK2 in various cellular processes, including DNA replication and cell division. Its application extends to cancer research, where it helps in understanding the pathways that lead to uncontrolled cell growth and in developing potential therapeutic strategies. Additionally, CVT-313 is employed in pharmacological studies to explore the effects of CDK2 inhibition on different types of cancer cells, providing insights into its potential as a targeted cancer treatment.